IN8bio (INAB) Short Interest Ratio & Short Volume → The new financial threat that could wipe out millions… (From InvestorPlace) (Ad) Free INAB Stock Alerts $1.01 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media IN8bio Short Interest DataCurrent Short Volume512,000 sharesPrevious Short Volume51,600 sharesChange Vs. Previous Month+892.25%Dollar Volume Sold Short$522,240.00Short Interest Ratio / Days to Cover1.5Last Record DateApril 15, 2024Outstanding Shares43,290,000 sharesFloat Size29,270,000 sharesShort Percent of Float1.75%Today's Trading Volume50,264 sharesAverage Trading Volume288,426 sharesToday's Volume Vs. Average17% Short Selling IN8bio ? Sign up to receive the latest short interest report for IN8bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINAB Short Interest Over TimeINAB Days to Cover Over TimeINAB Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now IN8bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024512,000 shares $522,240.00 +892.3%1.8%1.5 $1.02 3/31/202451,600 shares $60,888.00 -39.2%0.2%0.3 $1.18 3/15/202484,800 shares $96,672.00 +296.3%0.3%0.5 $1.14 2/29/202421,400 shares $23,754.00 -47.9%0.1%0 $1.11 2/15/202441,100 shares $45,210.00 -68.1%0.1%0.1 $1.10 1/31/2024129,000 shares $167,700.00 +49.1%0.5%0.2 $1.30 Get the Latest News and Ratings for INAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IN8bio and its competitors with MarketBeat's FREE daily newsletter. 1/15/202486,500 shares $131,480.00 -25.5%0.4%0.1 $1.52 12/31/2023116,100 shares $160,218.00 -77.9%0.7%0.2 $1.38 12/15/2023525,200 shares $1.00 million +490.1%2.9%0.9 $1.91 11/30/202389,000 shares $73,870.00 +222.5%0.4%0.6 $0.83 11/15/202327,600 shares $25,930.20 -51.0%0.1%0.3 $0.94 10/31/202356,300 shares $55,168.37 -0.2%0.3%0.7 $0.98 10/15/202356,400 shares $52,722.72 -43.1%0.3%0.5 $0.93 9/30/202399,100 shares $103,064.00 +166.4%0.5%0.8 $1.04 9/15/202337,200 shares $34,224.00 -57.4%0.2%0.3 $0.92 8/31/202387,300 shares $91,665.00 +90.2%0.4%0.5 $1.05 8/15/202345,900 shares $54,621.00 +81.4%0.2%0.2 $1.19 7/31/202325,300 shares $29,854.00 -70.1%0.1%0.1 $1.18 7/15/202384,700 shares $137,214.00 +22.2%0.6%0 $1.62 6/30/202369,300 shares $106,722.00 -21.9%0.5%0 $1.54 6/15/202388,700 shares $188,044.00 +14.8%0.6%0 $2.12 5/31/202377,300 shares $234,992.00 -43.8%0.6%0 $3.04 5/15/2023137,500 shares $338,250.00 -88.5%1.1%0 $2.46 4/30/20231,190,000 shares $1.74 million +720.7%13.5%0.3 $1.46 4/15/2023145,000 shares $175,450.00 -3.0%1.7%0.1 $1.21 3/31/2023149,500 shares $194,350.00 -9.4%1.7%1.9 $1.30 3/15/2023165,000 shares $219,450.00 -20.6%1.9%1.8 $1.33 2/28/2023207,800 shares $317,934.00 +127.4%2.4%2.2 $1.53 2/15/202391,400 shares $182,800.00 -13.7%1.1%1 $2.00 1/31/2023105,900 shares $243,146.40 -10.3%1.2%1.7 $2.30 1/15/2023118,000 shares $272,580.00 -10.4%1.4%1.9 $2.31 12/30/2022131,700 shares $304,227.00 +28.5%1.5%2 $2.31 12/15/2022102,500 shares $187,575.00 +45.8%1.2%1.7 $1.83 11/30/202270,300 shares $122,322.00 +42.9%0.8%1.1 $1.74 11/15/202249,200 shares $77,736.00 +21.8%0.6%0 $1.58 10/31/202240,400 shares $78,780.00 -9.0%0.5%0 $1.95 10/15/202244,400 shares $89,244.00 -13.3%0.5%0 $2.01 9/30/202251,200 shares $103,424.00 -40.5%0.6%0 $2.02 9/15/202286,100 shares $237,636.00 +154.7%1.0%0.1 $2.76 8/31/202233,800 shares $87,542.00 -17.2%0.8%0 $2.59Elon Musk Secret Crypto Plot Exposed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. INAB Short Interest - Frequently Asked Questions What is IN8bio's current short interest? Short interest is the volume of IN8bio shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 512,000 shares of INAB short. 1.75% of IN8bio's shares are currently sold short. Learn More on IN8bio's current short interest. What is a good short interest ratio for IN8bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INAB shares currently have a short interest ratio of 2.0. Learn More on IN8bio's short interest ratio. What is a good short interest percentage for IN8bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.75% of IN8bio's floating shares are currently sold short. Is IN8bio's short interest increasing or decreasing? IN8bio saw a increase in short interest in April. As of April 15th, there was short interest totaling 512,000 shares, an increase of 892.2% from the previous total of 51,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is IN8bio's float size? IN8bio currently has issued a total of 43,290,000 shares. Some of IN8bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. IN8bio currently has a public float of 29,270,000 shares. How does IN8bio's short interest compare to its competitors? 1.75% of IN8bio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to IN8bio: Cyclo Therapeutics, Inc. (0.47%), Dyadic International, Inc. (0.92%), OKYO Pharma Limited (0.50%), Quince Therapeutics, Inc. (6.21%), HCW Biologics Inc. (0.05%), SAB Biotherapeutics, Inc. (0.34%), Estrella Immunopharma, Inc. (0.05%), Achilles Therapeutics plc (0.10%), Protara Therapeutics, Inc. (4.35%), MiNK Therapeutics, Inc. (0.49%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short IN8bio stock? Short selling INAB is an investing strategy that aims to generate trading profit from IN8bio as its price is falling. INAB shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against IN8bio? A short squeeze for IN8bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INAB, which in turn drives the price of the stock up even further. How often is IN8bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INAB, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CYTH Short Interest DYAI Short Interest OKYO Short Interest QNCX Short Interest HCWB Short Interest SABS Short Interest ESLA Short Interest ACHL Short Interest TARA Short Interest INKT Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INAB) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing